Intech Investment Management LLC lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 54.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,485 shares of the company’s stock after selling 46,449 shares during the period. Intech Investment Management LLC’s holdings in Cardinal Health were worth $8,785,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Cardinal Health in the 2nd quarter worth approximately $6,293,115,000. Wellington Management Group LLP increased its holdings in Cardinal Health by 247.5% in the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after buying an additional 10,584,119 shares during the period. Bank of America Corp DE purchased a new position in Cardinal Health during the 2nd quarter worth approximately $689,066,000. Legal & General Group Plc purchased a new stake in shares of Cardinal Health in the 2nd quarter valued at $438,870,000. Finally, Pacer Advisors Inc. boosted its holdings in shares of Cardinal Health by 14.7% in the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock valued at $330,728,000 after acquiring an additional 200,021 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.
Cardinal Health Trading Down 1.6%
CAH stock opened at $279.29 on Wednesday. Cardinal Health, Inc. has a 12 month low of $180.45 and a 12 month high of $286.29. The company has a market cap of $64.55 billion, a price-to-earnings ratio of 36.13, a PEG ratio of 2.17 and a beta of 0.53. The firm has a 50-day moving average of $245.68 and a two-hundred day moving average of $225.95.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.94 by $0.32. The firm had revenue of $67.51 billion during the quarter, compared to analysts’ expectations of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. Cardinal Health’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the business earned $2.55 earnings per share. As a group, equities analysts forecast that Cardinal Health, Inc. will post 12.97 earnings per share for the current year.
Cardinal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be given a $0.5158 dividend. The ex-dividend date is Monday, January 4th. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. Cardinal Health’s payout ratio is currently 26.65%.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $260.00 to $286.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 10th. Wells Fargo & Company boosted their target price on shares of Cardinal Health from $277.00 to $321.00 and gave the company an “overweight” rating in a research report on Tuesday. Robert W. Baird increased their price target on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 12th. Argus lifted their price target on Cardinal Health from $264.00 to $309.00 and gave the company a “buy” rating in a research report on Thursday, November 12th. Finally, Citigroup upped their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $287.13.
Read Our Latest Stock Analysis on Cardinal Health
Cardinal Health Profile
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Read More
- Five stocks we like better than Cardinal Health
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
